Cardiac care must become integral to long-term HIV treatment, say experts
Source Entity
India Latest News: Top National Headlines Today & Breaking News | The Hindu
Medical experts at the 'HIV and Heart Symposium 2026' are calling for cardiovascular health to be prioritized in long-term HIV care. As antiretroviral therapy extends life expectancy, managing heart disease has become critical for those living with the virus.
Integrating Cardiovascular Care into HIV Management
The landscape of HIV treatment has undergone a monumental shift in recent decades. As highlighted at the 'HIV and Heart Symposium 2026', hosted by the Sri Jayadeva Institute of Cardiovascular Sciences and Research in collaboration with the AIDS Society of India, the success of antiretroviral therapy (ART) has transformed HIV from a fatal diagnosis into a manageable chronic condition. However, this success brings new challenges, specifically regarding the long-term health outcomes for patients who are now living significantly longer lives.
The Intersection of HIV and Heart Disease
As life expectancy for people living with HIV (PLHIV) continues to rise, clinicians are observing an increased incidence of comorbidities that were previously less concerning in the earlier stages of the epidemic. Cardiovascular disease (CVD) has emerged as a primary focus area for medical professionals. The symposium underscored that the physiological toll of chronic viral infection, combined with the metabolic side effects of some long-term antiretroviral regimens, necessitates a more proactive approach to heart health.
Changing Paradigms in Clinical Practice
Dr. H.S. Nataraj Setty, associate professor of cardiology and the event's course director, emphasized that the current paradigm must shift. It is no longer sufficient to focus solely on viral suppression; care must now be holistic. This means integrating routine cardiovascular screenings, lipid management, and lifestyle interventions directly into the standard of care for HIV patients. The collaboration between cardiologists and HIV specialists is a vital step toward creating a multidisciplinary strategy for patient longevity.
Addressing the Long-Term Burden
The symposium serves as a crucial platform for bridging the gap between infectious disease management and cardiology. By bringing these two fields together, experts aim to establish standardized protocols that address the unique cardiovascular risks faced by the HIV-positive community. This proactive stance is essential to mitigate the risk of heart disease, which is rapidly becoming one of the most significant hurdles to maintaining quality of life for long-term survivors.
Future Trends and Recommendations
Looking ahead, the integration of cardiovascular monitoring into HIV care packages is expected to become the global standard. Future trends suggest that as research continues to reveal the molecular links between HIV-induced inflammation and vascular damage, more specialized therapeutic interventions will be developed. The discussions at this symposium represent a vital step toward ensuring that the advancements in life-extending therapies are matched by a commitment to preventing secondary health complications.
Conclusion
In summary, the 'HIV and Heart Symposium 2026' has successfully elevated the discourse surrounding the long-term management of HIV. By prioritizing cardiovascular health, the medical community is addressing the next frontier in HIV care. Ensuring that heart health is an integral component of long-term treatment is not just a clinical recommendation, but a necessity for the health and well-being of the aging population of people living with HIV.
Verification Required?